Novo Nordisk A/S Increased Operating Profit by 27% in 2010

BAGSVAERD, DENMARK--(Marketwire - 02/02/11) - Novo Nordisk A/S (NYSE:NVO - News)

* Sales increased by 19% in Danish kroner and by 13% in local currencies.
o Sales of modern insulins increased by 24% (18% in local currencies).
o Sales of NovoSeven® increased by 14% (8% in local currencies).
o Sales of Victoza® reached DKK 2,317 million in 2010.